Asthma Global Clinical Trials Review, H1, 2017

Date: April 30, 2017
Pages: 1655
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A2F7004EE97EN
Leaflet:

Download PDF Leaflet

Asthma Global Clinical Trials Review, H1, 2017
Asthma Global Clinical Trials Review, H1, 2017

SUMMARY

GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H1, 2017' provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Asthma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Asthma
Mar 06, 2017: AB Science announces completion of patient recruitment for phase 3 study in severe persistent asthma
Mar 06, 2017: GSK's MUSCA study shows Nucala (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype
Mar 02, 2017: Cynata Advances Development of Cymerus MSCs for the Treatment of Asthma
Feb 27, 2017: ALKs ACARIZAX Data Results in Significant Change to the GINA Asthma Management Strategy
Feb 23, 2017: Positive Results for Relvar Ellipta Lung Function Study in Patients with Well-Controlled Asthma
Feb 14, 2017: Allergy Therapeutics Announces Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval
Feb 13, 2017: AnaptysBio to Present Data from ANB020 Program at Two Upcoming Medical Meetings
Clinical Trial Profile Snapshots
Appendix 1652
Abbreviations 1652
Definitions 1652
Research Methodology 1653
Secondary Research 1653
About GlobalData 1654
Contact Us 1654
Source 1655

LIST OF TABLES

Asthma Therapeutics, Global, Clinical Trials by Region, 2017*
Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Asthma Therapeutics Clinical Trials, North America, Top Countries, 2017*
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*
Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2017*
Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2017*
Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Asthma Therapeutics, Global, Clinical Trials by Phase, 2017*
Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

LIST OF FIGURES

Asthma Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2017* 15
Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2017* 18
Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Asthma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Asthma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 1653

COMPANIES MENTIONED

AstraZeneca Plc
GlaxoSmithKline Plc
Novartis AG
Merck & Co Inc
C. H. Boehringer Sohn AG & Co KG
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
Chiesi Farmaceutici SpA
Pfizer Inc
Quintiles IMS Holdings Inc
Skip to top


Ask Your Question

Asthma Global Clinical Trials Review, H1, 2017
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: